Noticias y vídeos - SUNESIS PHARMACEUTICALS INC.

...

Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement Shares of Viracta to commence trading on the Nasdaq Global Select Market on February 25, 2021 under ticker symbol 'VIRX' Cash and cash equivalents of over $120 million as of merger close Registration trial for the treatment of relapsed/refractory EBV-positive lymphoma expected to begin in 1H2021 PR Newswire SAN DIEGO, Feb. 24, 2021 SAN DIEGO , Feb. 24, 2021 /PRNewswire/ -- Viracta...

...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Sunesis Pharmaceuticals, Inc. (NasdaqGS: SNSS) with Viracta Therapeutics, Inc. pursuant to which Sunesis shareholders will end up owning just 14% of the combined company, subject to adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Sunesis Pharmaceuticals, Inc. - SNSS PR Newswire NEW YORK, Dec. 4, 2020 NEW YORK , Dec. 4, 2020 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Sunesis Pharmaceuticals, Inc. ("SNSS" or the "Company") ( SNSS ) relating to its proposed merger with Viracta Therapeutics,...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Sunesis Pharmaceuticals, Inc. (NasdaqGS: SNSS) with Viracta Therapeutics, Inc. pursuant to which Sunesis shareholders will end up owning just 14% of the combined company, subject to adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Sunesis Pharmaceuticals, Inc. PR Newswire NEW YORK, Nov. 30, 2020 NEW YORK , Nov. 30, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sunesis Pharmaceuticals, Inc. ("Sunesis " or the "Company") (NASDAQ: SNSS) in connection with the Company's proposed merger with privately-held Viracta Therapeutics, Inc. ("Viracta"). Under the terms of the merger agreement,...

...

Thinking about buying stock in Equillium, Under Armour, Alphabet, Sunesis Pharmaceuticals, or Zendesk? PR Newswire NEW YORK, Oct. 30, 2020 NEW YORK , Oct. 30, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EQ, UAA, GOOGL, SNSS, and ZEN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. EQ:...

...

...

...

...

...

...

...

...

...

...

...